Featured Topics
Learn more about 2026 ISPE Annual Meeting & Expo Conference Tracks
The 2026 ISPE Annual Meeting & Expo will bring together pharmaceutical and biopharmaceutical professionals from all levels of industry to engage in industry-critical discussions. This comprehensive education program offers cutting-edge technical sessions shedding light on the latest advancements in sustainability, operations, supply chain, facilities, production systems, equipment, information systems, product development, quality systems, regulatory guidance, and cutting-edge industry innovations. This signature gathering is not just an opportunity to learn but also to connect. From emerging leaders to seasoned executives in drug manufacturing, supply chain, devices, equipment, and services, and global regulatory agencies, participants will get have the opportunity to network, exchange insights, and preview the latest technologies and services at our expansive Expo Hall.
Digital, Data, and Decision Integrity
Using Data, Digital Tools, and AI to Support Good Decisions and Reliable Operations
This track showcases ways organizations are advancing Pharma 4.0 principles by integrating compliant digital technologies, robust data governance, and trustworthy AI into regulated life-science environments. Sessions feature case studies, frameworks, and innovations aligned with ISPE’s Pharma 4.0 operating model, GAMP 5 aligned lifecycle and risk-based validation approaches, and contemporary AI lifecycle governance. Sessions explore digital maturity enablement, data integrity by design, AI/ML lifecycle controls, autonomous or augmented decision-making, advanced analytics, digital twins, and smart/connected systems. Presentations highlight proven frameworks, case studies, practical outcomes, compliance considerations, challenges overcome, and approaches that enhance product quality, patient safety, and organizational decision integrity within a regulated digital ecosystem.
From Breakthrough to Bedside
Moving Scientific Innovation into Therapies that can be Made, Scaled, and Delivered
Innovative medicines across modalities—from small molecules and biologics to next-generation therapies like ATMPs, ADCs, Radiopharmaceuticals, mRNA —have the potential to transform patient outcomes. This track will explore the full pathway from discovery to delivery, emphasizing how scientific breakthroughs can be designed and developed to be manufacturable, scalable, and accessible. We will address practical manufacturing to fully automated/robotics and monitored applications and supply-chain challenges, differing global regulatory expectations, and strategies that accelerate responsible development, commercialization, and patient access.
Governance, Risk, and Readiness
Leading through Inspections, Uncertainty, and Change with Clarity and Accountability
Advances in technology and innovation are reshaping the landscape for Regulatory, Compliance and Quality. For example, the application of AI/ML alongside with sophisticated modeling techniques are catalyzing drug development for new and existing modalities. Participants in this track will hear from regulators working on novel ways to effectively collaborate and explore reliance initiatives that may benefit from a global perspective. Learn from industry leaders on approaches that may help introduce complex technologies and innovative medicines faster to patients around the world. Engage with peers and regulators in discussions that explore solutions to these challenges.
People, Capability, and the Workforce of Delivery
Building the Skills, Judgement, and Leadership Needed to Run Complex Systems
The future of pharmaceutical manufacturing workforce development is being reshaped by the rapid integration of AI, automation, and advanced data analytics across the product lifecycle. As organizations accelerate toward digital, continuous, and personalized manufacturing paradigms, the industry faces significant challenges in closing critical skill gaps while enabling a high performing agile workforce. This track highlights key trends shaping workforce readiness, including the emergence of new roles created by digital transformation, best practices for human/AI collaboration, strategies for addressing skill gaps and ongoing talent shortages, and approaches to retaining and developing talent in a rapidly evolving manufacturing environment. Presentations focus on practical frameworks, case studies, and scalable workforce development models are encouraged, especially those demonstrating measurable impact on capability building, performance, or organizational culture.
Systems That Deliver Reliably
Where Resilient Systems and Sustainable Operations Meet
This track focuses on the seamless integration of facilities, manufacturing, quality, supply chain and sustainability as interconnected systems that ensure reliable patient access to therapies. Presentations will demonstrate ways sustainability is actively embedded into core manufacturing operations, facility design, and the broader product lifecycle, highlighting measurable impact, including operational excellence, cost efficiency, emissions reduction, and enhanced supply resilience. Topics will illustrate how sustainable practices strengthen manufacturing and supply chain resiliency.